Detailseite
Projekt Druckansicht

Mechanismen der Einkapselung und Freisetzung von Alginat/rAAV-Genvektoren für eine verbesserte, sichere rAAV-vermittelter therapeutischer Gentransfer bei menschlichen Meniskusläsionen

Fachliche Zuordnung Orthopädie, Unfallchirurgie, rekonstruktive Chirurgie
Förderung Förderung von 2021 bis 2023
Projektkennung Deutsche Forschungsgemeinschaft (DFG) - Projektnummer 461955244
 
Erstellungsjahr 2023

Zusammenfassung der Projektergebnisse

The currently funded project allowed to generate highly promising data showing the value of alginate (AlgPH155) hydrogels as effective and safe systems to deliver clinically adapted therapeutic rAAV (FGF-2, TGF-β) vectors capable of stimulating the reparative activities in human meniscal fibrochondrocytes in vitro and in human experimental meniscal lesions in situ (relative to control conditions). Work continues to finalize the objectives 1 and 2 (tests of the approach in the presence of the neutralizing anti-AAV capsid antibody A20) and to perform objective 3 (experiments in vivo) that were delayed because of the COVID-19 pandemic limiting the access to the laboratory and facilities. Dissemination of the generated data at national and international conferences highlights the significance and potential impact of the research in the scientific community.

Projektbezogene Publikationen (Auswahl)

  • Benefits of alginate hydrogel-guided delivery of an rAAV FGF-2 vector to activate the reparative properties of human meniscal fibrochondrocytes. 2022 OARSI World Congress on Osteoarthritis, 2022, Berlin, Germany
    Venkatesan J. K. et al.
  • Overexpression of TGF- via rAAV gene transfer in an alginate hydrogel activates the healing capacities of human meniscal fibrochondrocytes. 2022 OARSI World Congress on Osteoarthritis, 2022, Berlin, Germany
    Venkatesan J. K. et al.
  • rAAV-mediated FGF-2 overexpression via alginate hydrogel delivery stimulates the reparative abilities of human meniscal fibrochondrocytes. 68th Annual Meeting of the Orthopaedic Research Society (ORS), 2022, Tampa, Florida, USA
    Venkatesan J. K. et al.
  • Alginate hydrogel-guided rAAV-mediated FGF-2 and TGF- overexpression activates the reparative properties in human meniscal lesion. 69th Annual Meeting of the Orthopaedic Research Society (ORS), 2023, Dallas, Texas, USA
    Venkatesan J. K. et al.
  • Benefits of alginate hydrogel-guided rAAV-mediated FGF-2 and TGF- overexpression on the reparative properties of human meniscal lesions. 2023 Deutscher Kongress für Orthopädie und Unfallchirurgie (DKOU), 2023, Berlin, Germany
    Venkatesan J. K. et al.
  • rAAV-mediated FGF-2 and TGF- overexpression via alginate hydrogel delivery stimulates the reparative abilities of human meniscal lesions in situ. 2023 OARSI World Congress on Osteoarthritis, 2023, Denver, Colorado, USA
    Venkatesan J. K. et al.
 
 

Zusatzinformationen

Textvergrößerung und Kontrastanpassung